CO5280227A1 - Composiciones de recubrimiento enterico en polvo que contienen una resina acrilica, un alcalinizante y un antiadherente - Google Patents

Composiciones de recubrimiento enterico en polvo que contienen una resina acrilica, un alcalinizante y un antiadherente

Info

Publication number
CO5280227A1
CO5280227A1 CO01009749A CO01009749A CO5280227A1 CO 5280227 A1 CO5280227 A1 CO 5280227A1 CO 01009749 A CO01009749 A CO 01009749A CO 01009749 A CO01009749 A CO 01009749A CO 5280227 A1 CO5280227 A1 CO 5280227A1
Authority
CO
Colombia
Prior art keywords
acrylic resin
percent
weight
alkalinizer
antiadherent
Prior art date
Application number
CO01009749A
Other languages
English (en)
Inventor
Ramireddy Chittamuru
George Reyes
Thomas P Farrell
Charles F Vesey
Dev K Mehra
Hans-Ulrich Petereit
Klaus Lehmann
Original Assignee
Bpsi Holdings Inc
Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bpsi Holdings Inc, Roehm Gmbh filed Critical Bpsi Holdings Inc
Publication of CO5280227A1 publication Critical patent/CO5280227A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)

Abstract

Una composición en polvo seca de recubrimiento de película entérica comestible no tóxica para su utilización enla fabricación de una suspensión entérica acuosa la cual podría ser utilizada para recubrir comprimidos farmacéuticos que comprende:a) una resina acrílica, dicha resina comprende: i) de 20 a 85 por ciento en peso de al menos una porción alquil acrilato o alquil metacrilato, ii) de 80 a 15 por ciento en peso de al menos una porción de vinilo o vinilideno que presenta un grupo de ácido carboxílico capaz de formar sal, y iii) de 0 a 30 por ciento en peso de al menos una porción de vinilo o vinilideno copolimerizable con i y ii,b) un agente de alcalización capaz de reaccionar con la resina acrílica tal que, luego de la reacción, 0.1 a 10 por ciento en moles de los grupos acídicos de 1a-ii están presentes en forma de sal, yc) un antiadherente. la composición en polvo seco de recubrimiento de película entérica de la reivindicación 1, que además incluye un plasticizador. La composición en polvo seco de recubrimiento de película entérica de la reivindicación 1, que además incluye un pigmento. La composición en polvo seco de recubrimiento de película entérica de la reivindicación 1, que además incluye un agente que ayuda a la fluencia. La composición en polvo seco de recubrimiento de película entérica de la reivindicación 1, que además incluye un tensioactivo. La composición en polvo seco de recubrimiento de película entérica de la reivindícación 1, que además incluye un agente antiaglomerante.
CO01009749A 2000-02-10 2001-02-09 Composiciones de recubrimiento enterico en polvo que contienen una resina acrilica, un alcalinizante y un antiadherente CO5280227A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/501,866 US6420473B1 (en) 2000-02-10 2000-02-10 Acrylic enteric coating compositions

Publications (1)

Publication Number Publication Date
CO5280227A1 true CO5280227A1 (es) 2003-05-30

Family

ID=23995328

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01009749A CO5280227A1 (es) 2000-02-10 2001-02-09 Composiciones de recubrimiento enterico en polvo que contienen una resina acrilica, un alcalinizante y un antiadherente

Country Status (11)

Country Link
US (2) US6420473B1 (es)
JP (1) JP4914552B2 (es)
AT (1) ATE489945T1 (es)
CO (1) CO5280227A1 (es)
DE (1) DE60143567D1 (es)
ES (1) ES2356706T3 (es)
IL (1) IL150850A (es)
SA (1) SA01210744B1 (es)
SI (1) SI1272165T1 (es)
TW (1) TWI283183B (es)
ZA (1) ZA200205843B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) * 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
DE10220470A1 (de) * 2002-04-30 2003-11-20 Roehm Gmbh ph-sensitives Polymer
EP1244468A2 (en) * 2000-01-07 2002-10-02 University Of Cincinnati Selective activation of a th1 or th2 lymphocyte regulated immune response
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
DE10044642A1 (de) * 2000-09-08 2002-03-21 Tfl Ledertechnik Gmbh & Co Kg Gefärbtes Leder und Färbeverfahren für gegerbtes Leder
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072729A1 (en) * 2001-05-15 2003-04-17 Christopher Szymczak Simethicone as weight gain enhancer
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US20030203019A1 (en) * 2002-04-30 2003-10-30 Cornelius John Mark Coated conditioners for use in foods and pharmaceuticals
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040166211A1 (en) * 2003-02-20 2004-08-26 Gesford Pamela K. Shellac-based film coatings containing pearlescent pigments and edible articles coated therewith
CN1750815B (zh) * 2003-02-20 2010-05-12 Bpsi控股公司 珠光膜涂层系统及其涂布基质
US20040166214A1 (en) * 2003-02-20 2004-08-26 Gesford Pamela K. Film coatings containing pearlescent pigments and edible articles coated therewith
US20060251724A1 (en) * 2003-05-06 2006-11-09 Farrell Thomas P Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
CN100508976C (zh) * 2003-07-24 2009-07-08 史密丝克莱恩比彻姆公司 口腔溶解薄膜
AU2005231145B8 (en) 2004-03-31 2010-11-11 Bpsi Holdings, Inc. Enteric coatings for orally ingestible substrates
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
PL1791530T3 (pl) * 2004-08-23 2009-01-30 Pejo Iserlohn Heilmittel Und Diaet Gmbh & Co Kg Kompozycja farmaceutyczna zawierająca psychostymulant
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
TW200626185A (en) * 2004-12-17 2006-08-01 Bpsi Holdings Inc Enteric film coating composition containing entericpolymer micronized with detackifier
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US20100029788A1 (en) * 2006-09-29 2010-02-04 John Pelesko Wet edible pearlescent film coatings
PL2099312T3 (pl) * 2006-12-14 2016-10-31 Kompozycje pigmentów perłowych oraz sposoby ich wytwarzania i zastosowania
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
CA2705518A1 (en) * 2007-11-13 2009-05-22 Hercules Incorporated Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
AU2009206204B2 (en) * 2008-01-25 2015-03-19 Alphapharm Pty Ltd Delayed release pharmaceutical composition of duloxetine
JP5466379B2 (ja) * 2008-06-30 2014-04-09 ツキオカフィルム製薬株式会社 フィルム状製剤及びフィルム状製剤の製造方法
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
SG2014014435A (en) 2009-02-24 2014-07-30 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
CN102421421A (zh) * 2009-05-12 2012-04-18 Bpsi控股有限责任公司 含有抗黏性剂细微颗粒的包衣和覆有该包衣的基体
WO2010132204A1 (en) 2009-05-12 2010-11-18 Bpsi Holdings, Llc. Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
MX2012001178A (es) * 2009-07-30 2012-03-07 Evonik Roehm Gmbh Composicion que consta de un material polimerico anionico y la sal de un acido monocarboxilico saturado que tiene 6 a 22 atomos de carbono.
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
WO2011085181A1 (en) * 2010-01-08 2011-07-14 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
WO2013045352A1 (de) 2011-09-30 2013-04-04 Basf Se Verfahren zur herstellung von festen pigmenthaltigen filmüberzugsmitteln in form von granulaten auf basis von magensaftresistenten filmbildnern für pharmazeutische dosierungsformen
US20140141075A1 (en) 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
MX357575B (es) * 2013-03-01 2018-07-16 Bpsi Holdings Llc Recubrimientos de pelicula de liberacion retardada que contienen silicato de calcio y sustratos recubiertos con los mismos.
US20170216328A1 (en) 2014-04-04 2017-08-03 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration
EP3370748B1 (en) 2015-11-03 2022-06-08 The Brigham and Women's Hospital, Inc. Therapeutic microbiota for the treatment and/or prevention of food allergy
BR112019004033A2 (pt) * 2016-09-07 2019-05-28 Saniona As composição farmacêutica oral estável, processo para preparar a composição, método, e, uso da composição farmacêutica
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
KR20200143724A (ko) * 2018-04-12 2020-12-24 비피에스아이 홀딩스, 엘엘씨. 산성화 코팅 및 코팅된 분해 저항성 기질
EP3610862A1 (en) * 2018-08-14 2020-02-19 Apillet APS Novel oral composition
CA3111795A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
PT3891267T (pt) 2018-11-05 2024-07-04 Marvelbiome Inc Composições microbianas que compreendem elagitanina e métodos de utilização
CA3143713A1 (en) 2019-06-19 2020-12-24 Solarea Bio, Inc. Microbial compositions and methods for producing upgraded probiotic assemblages
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
WO2024120944A1 (en) 2022-12-09 2024-06-13 Evonik Operations Gmbh Delayed release composition with resistance against fed state gastric conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
DE3208791A1 (de) * 1982-03-11 1983-09-22 Röhm GmbH, 6100 Darmstadt Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
ZA86252B (en) * 1985-01-30 1986-09-24 Warner Lambert Co Coated dosage forms
US4855402A (en) * 1985-11-25 1989-08-08 The Goodyear Tire & Rubber Company Self-emulsifiable resin powder
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
JP2917799B2 (ja) 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
US5733575A (en) * 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
DE19626045C2 (de) * 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування

Also Published As

Publication number Publication date
SA01210744B1 (ar) 2006-10-29
DE60143567D1 (de) 2011-01-13
JP4914552B2 (ja) 2012-04-11
JP2003522139A (ja) 2003-07-22
US20010022972A1 (en) 2001-09-20
SI1272165T1 (sl) 2011-03-31
ES2356706T3 (es) 2011-04-12
ZA200205843B (en) 2003-10-22
US6420473B1 (en) 2002-07-16
TWI283183B (en) 2007-07-01
IL150850A (en) 2007-06-17
ATE489945T1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
CO5280227A1 (es) Composiciones de recubrimiento enterico en polvo que contienen una resina acrilica, un alcalinizante y un antiadherente
ES2610481T3 (es) Tratamiento de agua recreativa
CA1069826A (en) Slowly neutralized solid cleaning denture composition
ATE376414T1 (de) Pellet formulierung mit gesteuerter freisetzung
JP2003213038A5 (es)
BR0002138A (pt) Composição de polìmero, processo para aumentar o tempo de abertura de uma composição cimentosa aquosa, e, uso de uma composição de polìmero
ME00864B (me) Farmaceutski sastav koji sadrži inhibitore protonske pumpe
KR900011454A (ko) 압축 성형 제제
TR200801943T1 (tr) İnce tabaka oluşturan yayıcı maddeler.
TW200626185A (en) Enteric film coating composition containing entericpolymer micronized with detackifier
CA2397832A1 (en) Acrylic enteric coating compositions
AR044861A1 (es) Una composicion para pelicula consumible via oral para suministrar agentes antiplaca y refrescantes del aliento
AR044864A1 (es) Composiciones orales antiplaca acuosas estables
CA2797809A1 (en) Enteric tablet
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
EA200200627A1 (ru) Адгезионные композиции для зубных протезов, включающие полимерный активатор
SE0201110D0 (sv) New film coating
AR034545A1 (es) Composiciones de recubrimiento entericas acrilicas
NO884226D0 (no) Korrosjonsbeskyttelsesmiddel.
BR9916021A (pt) Composições farmacêuticas contendo quinaprilmagnésio
JP2006104141A5 (es)
JPS5712078A (en) Aqueous adhesive composition
ATE173612T1 (de) Flüssigantazidzusammensetzungen
JPS5520753A (en) Antibacterial and antimold composition
ATE285215T1 (de) Zusammensetzung für die stabilisation von zahnprothesen

Legal Events

Date Code Title Description
FG Application granted